Table: Aska Pharmaceutical - 9-MTH group results

ASKA Pharmaceutical Holdings

04/02/2019 07:00

Feb 4 (Reuters)- 
             Aska Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2018        Dec 31, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             37.02               38.71            48.00    
                 (-4.4 pct)          (+3.3 pct)       (-1.9 pct)  
  Operating          2.58                3.46             2.00    
                 (-25.5 pct)         (+75.2 pct)      (-29.2 pct) 
  Recurring          2.80                3.69             2.10    
                 (-24.1 pct)         (+68.1 pct)      (-31.7 pct) 
  Net                2.22                3.03             1.60    
                 (-26.8 pct)         (-22.6 pct)      (-33.0 pct) 
  EPS             78.55 yen          107.46 yen        56.66 yen  
  Ann Div                             14.00 yen        14.00 yen  
  -Q2 div         7.00 yen            7.00 yen                    
  -Q4 div                             7.00 yen         7.00 yen   
  
  NOTE - Aska Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T